Lupin Limited (BOM:500257)

India · Delayed Price · Currency is INR

2,442.35

+98.95 (4.22%)

At close: May 6, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	226.04B	199.45B	166.42B	164.05B	151.63B
Pharmaceuticals Growth	13.33%	19.85%	1.44%	8.19%	-1.38%
Others	1.05B	671.40M	-	-	-
Others Growth	57.06%	-	-	-	-
Inter Segment Revenue	-18.60M	-15.20M	-	-	-
Total	227.08B	200.11B	166.42B	164.05B	151.63B
Total Growth	13.48%	20.25%	1.44%	8.19%	-1.38%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	85.05B	73.17B	66.51B	64.60B	59.32B
India Growth	16.24%	10.01%	2.96%	8.90%	1.14%
USA	77.24B	71.05B	51.58B	56.35B	54.02B
USA Growth	8.71%	37.73%	-8.46%	4.31%	-4.27%
Others	64.79B	55.89B	48.33B	43.11B	38.29B
Others Growth	15.92%	15.66%	12.11%	12.58%	1.89%
Total	227.08B	200.11B	166.42B	164.05B	151.63B
Total Growth	13.48%	20.25%	1.44%	8.19%	-1.38%

Source: S&P Global Market Intelligence.